×

WHY INVEST WITH MEDTECH SYNDICATE?

What Defines an Angel Investor?

The Syndicate consists of active angel investors, meaning we engage directly in the entrepreneurial journey. We offer strategic advice to startups and use our extensive network to address operational challenges.

What’s in it for you?

  • Access: We are in contact with key university incubators and other angel networks (including the Ireland-wide HBAN network) and provide a steady pipeline of pre-screened investment opportunities in the medtech sector. 
  • Independence: Each member independently steers their investment decisions, yet we share opportunities, insights and experience, fostering a supportive environment. 
  • Influence: This collaborative approach enhances our negotiation power with startups, ensuring better terms. 
  • Financial Benefits: In addition to the potential financial profits at exit, many of our investments qualify for the Irish Employment Investment Incentive Scheme (EIIS) which maximises the benefits for our members.
  • Giving back: The syndicate operates with the public good at its core.  By pooling resources, we strategically fund cutting-edge medical technologies, advance medical innovation and promise significant improvements in patient outcomes.
  • Camaraderie: As seasoned business angels, we know it can be a bit of a lonely road. Our syndicate was established to provide a sense of camaraderie and to guide newcomers through the complexities of angel investing.
Meet The Team
Untitled design

Understanding an Angel Syndicate

Adhering to our philosophy of active investment, for each company we designate a ‘Deal Lead’ who represents all investing members’ interests.

This approach streamlines communication between entrepreneurs and our members. Typically, and depending on the size of the investment, our Deal Lead also secures a board position in the newly invested startup, ensuring direct involvement and oversight

  • Joining the MedTech Syndicate has allowed me to leverage collective intelligence and resources, ultimately driving better investment outcomes. The camaraderie and support from fellow investors are invaluable
    Ultan M
  • In the absence of a current specialist medtech VC, the presence of the Medtech Syndicate has supported innovation in the start up sector. The syndicate’s collective knowledge and strategic partnerships have made it easier to evaluate and close on more investments, accelerating my deal flow and increasing my overall portfolio. The collaborative environment fosters shared expertise, reduces due diligence work and enables me to make more informed investment decisions
    Bernard C
  • Investing with the MedTech Syndicate has been a game-changer for me. The collaboration and shared expertise within the group have led to informed decision-making and a diversified portfolio that I couldn't have achieved alone.
    John L
  • Investing with the MedTech Syndicate has been of real interest to me.  The collaboration and shared expertise within the group have led to informed decision-making and a diversified portfolio that I couldn't have achieved alone. It allows us to use our own thoughts and collaborate with colleagues to see if something is worth investing in. It is definitely for a long term strategy and at the higher end of the risk scale. Having this as a smaller percentage of a persons investing strategy can lead to some interesting journeys and hopefully stellar returns. The thing that I enjoy most is having combined expertise in the room looking at the same pitch and different views emerging with some overall consensus.
    Dermot T

WANT TO KNOW MORE ABOUT MEDTECH?

Why not join our next investor pitch meeting?

Join Our Next Pitch
Copyright Medtech Syndicate ©2025 all rights reserved